RADX Annual Cash & Cash Equivalents
$12.42 M
+$4.67 M+60.33%
01 June 2024
Summary:
As of January 30, 2025, RADX annual cash & cash equivalents is $12.42 million, with the most recent change of +$4.67 million (+60.33%) on June 1, 2024. During the last 3 years, it has fallen by -$6.14 million (-33.10%). RADX annual cash & cash equivalents is now -33.10% below its all-time high of $18.56 million, reached on June 1, 2022.RADX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RADX Quarterly Cash And Cash Equivalents
$12.42 M
+$11.13 M+862.23%
01 June 2024
Summary:
As of January 30, 2025, RADX quarterly cash and cash equivalents is $12.42 million, with the most recent change of +$11.13 million (+862.23%) on June 1, 2024. Over the past year, it has stayed the same.RADX quarterly cash and cash equivalents is now -47.45% below its all-time high of $23.62 million, reached on December 1, 2021.RADX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RADX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +60.3% | 0.0% |
| 3 y3 years | -33.1% | 0.0% |
| 5 y5 years | -33.1% | 0.0% |
RADX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.1% | +60.3% | -47.5% | +862.2% |
| 5 y | 5-year | -33.1% | +60.3% | -47.5% | +862.2% |
| alltime | all time | -33.1% | +60.3% | -47.5% | +862.2% |
Radiopharm Theranostics Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | $12.42 M(+60.3%) | $12.42 M(+862.2%) |
| Dec 2023 | - | $1.29 M(-83.3%) |
| June 2023 | $7.74 M | $7.74 M(-53.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | - | $16.49 M(-11.1%) |
| June 2022 | $18.56 M | $18.56 M(-21.4%) |
| Dec 2021 | - | $23.62 M |
FAQ
- What is Radiopharm Theranostics Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Radiopharm Theranostics Limited?
- What is Radiopharm Theranostics Limited annual cash & cash equivalents year-on-year change?
- What is Radiopharm Theranostics Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Radiopharm Theranostics Limited?
- What is Radiopharm Theranostics Limited quarterly cash and cash equivalents year-on-year change?
What is Radiopharm Theranostics Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of RADX is $12.42 M
What is the all time high annual cash & cash equivalents for Radiopharm Theranostics Limited?
Radiopharm Theranostics Limited all-time high annual cash & cash equivalents is $18.56 M
What is Radiopharm Theranostics Limited annual cash & cash equivalents year-on-year change?
Over the past year, RADX annual cash & cash equivalents has changed by +$4.67 M (+60.33%)
What is Radiopharm Theranostics Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RADX is $12.42 M
What is the all time high quarterly cash and cash equivalents for Radiopharm Theranostics Limited?
Radiopharm Theranostics Limited all-time high quarterly cash and cash equivalents is $23.62 M
What is Radiopharm Theranostics Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, RADX quarterly cash and cash equivalents has changed by $0.00 (0.00%)